Bhagiradha Chemicals & Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 22, 2025, 10:50 am

Market Cap	3,250 Cr.
Current Price	252
High / Low	365/228
Stock P/E	123
Book Value	54.9
Dividend Yield	0.06 %
ROCE	7.44 %
ROE	4.91 %
Face Value	1.00
PEG Ratio	-12.34

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Bhagiradha Chemicals & Industries Ltd

Competitors of Bhagiradha Chemicals & Industries Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Epigral Ltd	6,258 Cr.	1,452	2,196/1,440	15.6	487	0.41 %	24.9 %	22.3 %	10.0
Dharmaj Crop Guard Ltd	860 Cr.	253	391/165	17.7	131	0.00 %	12.0 %	9.28 %	10.0
Bhaskar Agrochemicals Ltd	64.7 Cr.	124	149/56.6	11.6	40.0	0.00 %	21.3 %	24.7 %	10.0
Bhagiradha Chemicals & Industries Ltd	3,250 Cr.	252	365/228	123	54.9	0.06 %	7.44 %	4.91 %	1.00
Best Agrolife Ltd	710 Cr.	300	670/244	55.5	342	1.00 %	12.9 %	9.95 %	10.0
Industry Average	11,119.20 Cr	1,490.43		32.33	472.46	0.45%	15.21%	19.87%	7.25

All Competitor Stocks of Bhagiradha Chemicals & Industries Ltd

Quarterly Result

Metric	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Sales	121.72	131.81	126.00	122.57	100.01	122.01	74.37	110.32	110.78	100.22	102.73	122.63	123.78
Expenses	102.10	111.47	106.39	104.28	92.80	108.45	66.19	96.37	98.94	90.47	93.43	115.39	113.78
Operating Profit	19.62	20.34	19.61	18.29	7.21	13.56	8.18	13.95	11.84	9.75	9.30	7.24	10.00
OPM %	16.12%	15.43%	15.56%	14.92%	7.21%	11.11%	11.00%	12.65%	10.69%	9.73%	9.05%	5.90%	8.08%
Other Income	0.20	0.51	0.62	0.51	0.42	0.48	1.38	2.53	3.64	5.24	5.50	6.10	3.50
Interest	1.77	0.82	0.84	1.55	1.72	2.26	1.57	2.14	1.34	1.65	2.29	1.36	2.93
Depreciation	2.30	2.40	2.45	2.51	2.61	2.70	2.82	2.83	2.82	2.91	3.11	3.10	3.36
Profit before tax	15.75	17.63	16.94	14.74	3.30	9.08	5.17	11.51	11.32	10.43	9.40	8.88	7.21
Tax %	23.94%	28.93%	28.57%	33.38%	33.33%	30.62%	28.63%	29.37%	36.13%	24.45%	24.15%	41.89%	-14.84%
Net Profit	11.98	12.52	12.09	9.82	2.20	6.29	3.69	8.12	7.23	7.87	7.13	5.16	8.29
EPS in Rs	1.15	1.20	1.16	0.94	0.21	0.60	0.35	0.78	0.58	0.63	0.57	0.40	0.64

Last Updated: August 19, 2025, 10:20 pm

Below is a detailed analysis of the quarterly data for Bhagiradha Chemicals & Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

For Sales, as of Jun 2025, the value is 123.78 Cr.. The value appears strong and on an upward trend. It has increased from 122.63 Cr. (Mar 2025) to 123.78 Cr., marking an increase of 1.15 Cr..
For Expenses, as of Jun 2025, the value is 113.78 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 115.39 Cr. (Mar 2025) to 113.78 Cr., marking a decrease of 1.61 Cr..
For Operating Profit, as of Jun 2025, the value is 10.00 Cr.. The value appears strong and on an upward trend. It has increased from 7.24 Cr. (Mar 2025) to 10.00 Cr., marking an increase of 2.76 Cr..
For OPM %, as of Jun 2025, the value is 8.08%. The value appears strong and on an upward trend. It has increased from 5.90% (Mar 2025) to 8.08%, marking an increase of 2.18%.
For Other Income, as of Jun 2025, the value is 3.50 Cr.. The value appears to be declining and may need further review. It has decreased from 6.10 Cr. (Mar 2025) to 3.50 Cr., marking a decrease of 2.60 Cr..
For Interest, as of Jun 2025, the value is 2.93 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.36 Cr. (Mar 2025) to 2.93 Cr., marking an increase of 1.57 Cr..
For Depreciation, as of Jun 2025, the value is 3.36 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.10 Cr. (Mar 2025) to 3.36 Cr., marking an increase of 0.26 Cr..
For Profit before tax, as of Jun 2025, the value is 7.21 Cr.. The value appears to be declining and may need further review. It has decreased from 8.88 Cr. (Mar 2025) to 7.21 Cr., marking a decrease of 1.67 Cr..
For Tax %, as of Jun 2025, the value is -14.84%. The value appears to be improving (decreasing) as expected. It has decreased from 41.89% (Mar 2025) to -14.84%, marking a decrease of 56.73%.
For Net Profit, as of Jun 2025, the value is 8.29 Cr.. The value appears strong and on an upward trend. It has increased from 5.16 Cr. (Mar 2025) to 8.29 Cr., marking an increase of 3.13 Cr..
For EPS in Rs, as of Jun 2025, the value is 0.64. The value appears strong and on an upward trend. It has increased from 0.40 (Mar 2025) to 0.64, marking an increase of 0.24.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 3:47 am

Metric	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	174	220	152	203	183	384	246	318	436	502	407	436	484
Expenses	164	209	148	191	172	343	229	271	367	424	364	398	443
Operating Profit	11	11	4	11	12	41	17	47	68	78	43	38	41
OPM %	6%	5%	3%	6%	6%	11%	7%	15%	16%	16%	11%	9%	8%
Other Income	1	1	1	2	-8	1	4	2	1	2	5	20	16
Interest	4	6	7	7	7	8	5	8	9	5	8	7	10
Depreciation	5	3	4	4	3	5	7	8	9	10	11	12	13
Profit before tax	2	3	-5	3	-6	29	9	32	51	65	29	40	33
Tax %	10%	17%	-39%	61%	-77%	37%	27%	27%	30%	29%	30%	32%
Net Profit	2	3	-3	1	-1	18	7	23	36	46	20	27	26
EPS in Rs	0.31	0.40	-0.51	0.16	-0.14	1.78	0.63	2.28	3.50	4.46	1.95	2.11	2.07
Dividend Payout %	26%	20%	0%	0%	0%	9%	0%	0%	7%	9%	5%	7%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	50.00%	-200.00%	133.33%	-200.00%	1900.00%	-61.11%	228.57%	56.52%	27.78%	-56.52%	35.00%
Change in YoY Net Profit Growth (%)	0.00%	-250.00%	333.33%	-333.33%	2100.00%	-1961.11%	289.68%	-172.05%	-28.74%	-84.30%	91.52%

Bhagiradha Chemicals & Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	7%
5 Years:	12%
3 Years:	0%
TTM:	8%

Compounded Profit Growth
10 Years:	27%
5 Years:	40%
3 Years:	-9%
TTM:	12%

Stock Price CAGR
10 Years:	43%
5 Years:	56%
3 Years:	27%
1 Year:	-33%

Return on Equity
10 Years:	9%
5 Years:	10%
3 Years:	8%
Last Year:	5%

Last Updated: September 5, 2025, 2:41 pm

No data available for the Balance Sheet data table.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	3	1	18	8	-27	49	48	4	7	13	39	-1
Cash from Investing Activity +	-14	-15	-0	-6	-13	-38	-39	-21	-17	-59	-123	-250
Cash from Financing Activity +	10	13	-17	-2	43	-12	-9	15	12	46	88	260
Net Cash Flow	-2	-1	1	-0	3	-1	0	-2	2	-0	5	9

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	71	82	67	31	71	80	17	68	81	94	95	145
Inventory Days	99	139	256	282	281	77	137	97	91	108	166	158
Days Payable	104	143	216	205	191	110	59	89	73	69	95	135
Cash Conversion Cycle	66	78	106	108	161	47	95	76	99	132	167	169
Working Capital Days	4	-0	-19	-21	49	16	-12	21	32	91	120	395
ROCE %	7%	8%	0%	8%	7%	22%	7%	20%	25%	22%	9%	7%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Promoters	23.52%	23.52%	23.52%	23.52%	23.52%	23.52%	20.27%	20.27%	20.27%	19.75%	19.75%	19.60%
FIIs	0.10%	0.10%	0.12%	0.10%	0.17%	0.16%	0.17%	0.15%	0.18%	0.04%	0.05%	0.05%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	3.14%	3.14%	3.08%	2.89%	2.89%	2.89%
Public	76.39%	76.39%	76.37%	76.38%	76.32%	76.33%	76.42%	76.44%	76.46%	77.33%	77.31%	77.48%
No. of Shareholders	3,465	3,408	3,524	3,941	3,747	4,292	11,298	15,101	14,762	13,883	13,911	13,761

Shareholding Pattern Chart

No. of Shareholders

Bhagiradha Chemicals & Industries Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
FaceValue	1.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	1.14	17.51	44.35	43.02	28.06
Diluted EPS (Rs.)	1.14	16.10	44.35	43.02	28.06
Cash EPS (Rs.)	2.14	28.06	52.82	53.37	37.78
Book Value[Excl.RevalReserv]/Share (Rs.)	52.61	397.59	301.04	227.82	186.80
Book Value[Incl.RevalReserv]/Share (Rs.)	52.61	397.59	301.04	227.82	186.80
Revenue From Operations / Share (Rs.)	33.97	391.76	482.52	522.74	381.44
PBDIT / Share (Rs.)	3.56	43.81	75.52	82.94	57.02
PBIT / Share (Rs.)	2.50	33.26	66.10	72.47	47.22
PBT / Share (Rs.)	1.95	25.87	61.30	61.56	38.57
Net Profit / Share (Rs.)	1.07	17.51	43.39	42.89	27.98
NP After MI And SOA / Share (Rs.)	1.07	17.51	43.39	42.89	27.98
PBDIT Margin (%)	10.49	11.18	15.65	15.86	14.94
PBIT Margin (%)	7.34	8.49	13.69	13.86	12.38
PBT Margin (%)	5.73	6.60	12.70	11.77	10.11
Net Profit Margin (%)	3.14	4.46	8.99	8.20	7.33
NP After MI And SOA Margin (%)	3.14	4.46	8.99	8.20	7.33
Return on Networth / Equity (%)	2.03	4.40	14.41	18.82	14.97
Return on Capital Employeed (%)	4.38	7.68	19.86	28.84	22.10
Return On Assets (%)	1.48	3.16	10.10	10.45	8.53
Long Term Debt / Equity (X)	0.04	0.04	0.05	0.05	0.12
Total Debt / Equity (X)	0.12	0.14	0.15	0.42	0.37
Asset Turnover Ratio (%)	0.58	0.79	1.27	1.42	1.28
Current Ratio (X)	1.92	2.23	2.27	1.31	1.20
Quick Ratio (X)	1.26	1.34	1.36	0.79	0.66
Inventory Turnover Ratio (X)	3.65	2.69	4.23	4.66	3.68
Dividend Payout Ratio (NP) (%)	8.97	17.13	6.91	2.32	0.00
Dividend Payout Ratio (CP) (%)	4.48	10.68	5.67	1.86	0.00
Earning Retention Ratio (%)	91.03	82.87	93.09	97.68	0.00
Cash Earning Retention Ratio (%)	95.52	89.32	94.33	98.14	0.00
Interest Coverage Ratio (X)	6.50	5.93	15.74	7.61	5.75
Interest Coverage Ratio (Post Tax) (X)	2.95	3.37	10.04	4.93	3.69
Enterprise Value (Cr.)	3659.46	1726.83	1291.27	923.65	478.11
EV / Net Operating Revenue (X)	8.31	4.24	2.57	2.12	1.50
EV / EBITDA (X)	79.16	37.88	16.43	13.36	10.06
MarketCap / Net Operating Revenue (X)	8.18	4.11	2.48	1.94	1.32
Retention Ratios (%)	91.02	82.86	93.08	97.67	0.00
Price / BV (X)	5.28	4.05	3.98	4.46	2.70
Price / Net Operating Revenue (X)	8.18	4.11	2.48	1.94	1.32
EarningsYield	0.00	0.01	0.03	0.04	0.05

After reviewing the key financial ratios for Bhagiradha Chemicals & Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. It has decreased from 10.00 (Mar 24) to 1.00, marking a decrease of 9.00.
For Basic EPS (Rs.), as of Mar 25, the value is 1.14. This value is below the healthy minimum of 5. It has decreased from 17.51 (Mar 24) to 1.14, marking a decrease of 16.37.
For Diluted EPS (Rs.), as of Mar 25, the value is 1.14. This value is below the healthy minimum of 5. It has decreased from 16.10 (Mar 24) to 1.14, marking a decrease of 14.96.
For Cash EPS (Rs.), as of Mar 25, the value is 2.14. This value is below the healthy minimum of 3. It has decreased from 28.06 (Mar 24) to 2.14, marking a decrease of 25.92.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 52.61. It has decreased from 397.59 (Mar 24) to 52.61, marking a decrease of 344.98.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 52.61. It has decreased from 397.59 (Mar 24) to 52.61, marking a decrease of 344.98.
For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 33.97. It has decreased from 391.76 (Mar 24) to 33.97, marking a decrease of 357.79.
For PBDIT / Share (Rs.), as of Mar 25, the value is 3.56. This value is within the healthy range. It has decreased from 43.81 (Mar 24) to 3.56, marking a decrease of 40.25.
For PBIT / Share (Rs.), as of Mar 25, the value is 2.50. This value is within the healthy range. It has decreased from 33.26 (Mar 24) to 2.50, marking a decrease of 30.76.
For PBT / Share (Rs.), as of Mar 25, the value is 1.95. This value is within the healthy range. It has decreased from 25.87 (Mar 24) to 1.95, marking a decrease of 23.92.
For Net Profit / Share (Rs.), as of Mar 25, the value is 1.07. This value is below the healthy minimum of 2. It has decreased from 17.51 (Mar 24) to 1.07, marking a decrease of 16.44.
For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 1.07. This value is below the healthy minimum of 2. It has decreased from 17.51 (Mar 24) to 1.07, marking a decrease of 16.44.
For PBDIT Margin (%), as of Mar 25, the value is 10.49. This value is within the healthy range. It has decreased from 11.18 (Mar 24) to 10.49, marking a decrease of 0.69.
For PBIT Margin (%), as of Mar 25, the value is 7.34. This value is below the healthy minimum of 10. It has decreased from 8.49 (Mar 24) to 7.34, marking a decrease of 1.15.
For PBT Margin (%), as of Mar 25, the value is 5.73. This value is below the healthy minimum of 10. It has decreased from 6.60 (Mar 24) to 5.73, marking a decrease of 0.87.
For Net Profit Margin (%), as of Mar 25, the value is 3.14. This value is below the healthy minimum of 5. It has decreased from 4.46 (Mar 24) to 3.14, marking a decrease of 1.32.
For NP After MI And SOA Margin (%), as of Mar 25, the value is 3.14. This value is below the healthy minimum of 8. It has decreased from 4.46 (Mar 24) to 3.14, marking a decrease of 1.32.
For Return on Networth / Equity (%), as of Mar 25, the value is 2.03. This value is below the healthy minimum of 15. It has decreased from 4.40 (Mar 24) to 2.03, marking a decrease of 2.37.
For Return on Capital Employeed (%), as of Mar 25, the value is 4.38. This value is below the healthy minimum of 10. It has decreased from 7.68 (Mar 24) to 4.38, marking a decrease of 3.30.
For Return On Assets (%), as of Mar 25, the value is 1.48. This value is below the healthy minimum of 5. It has decreased from 3.16 (Mar 24) to 1.48, marking a decrease of 1.68.
For Long Term Debt / Equity (X), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.04.
For Total Debt / Equity (X), as of Mar 25, the value is 0.12. This value is within the healthy range. It has decreased from 0.14 (Mar 24) to 0.12, marking a decrease of 0.02.
For Asset Turnover Ratio (%), as of Mar 25, the value is 0.58. It has decreased from 0.79 (Mar 24) to 0.58, marking a decrease of 0.21.
For Current Ratio (X), as of Mar 25, the value is 1.92. This value is within the healthy range. It has decreased from 2.23 (Mar 24) to 1.92, marking a decrease of 0.31.
For Quick Ratio (X), as of Mar 25, the value is 1.26. This value is within the healthy range. It has decreased from 1.34 (Mar 24) to 1.26, marking a decrease of 0.08.
For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.65. This value is below the healthy minimum of 4. It has increased from 2.69 (Mar 24) to 3.65, marking an increase of 0.96.
For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 8.97. This value is below the healthy minimum of 20. It has decreased from 17.13 (Mar 24) to 8.97, marking a decrease of 8.16.
For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 4.48. This value is below the healthy minimum of 20. It has decreased from 10.68 (Mar 24) to 4.48, marking a decrease of 6.20.
For Earning Retention Ratio (%), as of Mar 25, the value is 91.03. This value exceeds the healthy maximum of 70. It has increased from 82.87 (Mar 24) to 91.03, marking an increase of 8.16.
For Cash Earning Retention Ratio (%), as of Mar 25, the value is 95.52. This value exceeds the healthy maximum of 70. It has increased from 89.32 (Mar 24) to 95.52, marking an increase of 6.20.
For Interest Coverage Ratio (X), as of Mar 25, the value is 6.50. This value is within the healthy range. It has increased from 5.93 (Mar 24) to 6.50, marking an increase of 0.57.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.95. This value is below the healthy minimum of 3. It has decreased from 3.37 (Mar 24) to 2.95, marking a decrease of 0.42.
For Enterprise Value (Cr.), as of Mar 25, the value is 3,659.46. It has increased from 1,726.83 (Mar 24) to 3,659.46, marking an increase of 1,932.63.
For EV / Net Operating Revenue (X), as of Mar 25, the value is 8.31. This value exceeds the healthy maximum of 3. It has increased from 4.24 (Mar 24) to 8.31, marking an increase of 4.07.
For EV / EBITDA (X), as of Mar 25, the value is 79.16. This value exceeds the healthy maximum of 15. It has increased from 37.88 (Mar 24) to 79.16, marking an increase of 41.28.
For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 8.18. This value exceeds the healthy maximum of 3. It has increased from 4.11 (Mar 24) to 8.18, marking an increase of 4.07.
For Retention Ratios (%), as of Mar 25, the value is 91.02. This value exceeds the healthy maximum of 70. It has increased from 82.86 (Mar 24) to 91.02, marking an increase of 8.16.
For Price / BV (X), as of Mar 25, the value is 5.28. This value exceeds the healthy maximum of 3. It has increased from 4.05 (Mar 24) to 5.28, marking an increase of 1.23.
For Price / Net Operating Revenue (X), as of Mar 25, the value is 8.18. This value exceeds the healthy maximum of 3. It has increased from 4.11 (Mar 24) to 8.18, marking an increase of 4.07.
For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Bhagiradha Chemicals & Industries Ltd as of November 25, 2025 is: 265.41

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of November 25, 2025, Bhagiradha Chemicals & Industries Ltd is Undervalued by 5.32% compared to the current share price 252.00

Intrinsic Value of Bhagiradha Chemicals & Industries Ltd as of November 25, 2025 is: 238.94

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of November 25, 2025, Bhagiradha Chemicals & Industries Ltd is Overvalued by 5.18% compared to the current share price 252.00

Last 5 Year EPS CAGR: -9.97%

*Investments are subject to market risks

Strength and Weakness

Unable to fetch valid data for stock valuation.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Bhagiradha Chemicals & Industries Ltd:
1. Net Profit Margin: 3.14%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 4.38% (Industry Average ROCE: 15.21%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 2.03% (Industry Average ROE: 19.87%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 2.95
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 1.26
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 123 (Industry average Stock P/E: 32.33)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.12
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating: